Is Early Palliative Care Feasible in Patients With Multiple Myeloma? Josep Porta-Sales, MD, PhD, Maria Guerrero-Torrelles, RN, Deborah Moreno-Alonso, MD, Josep Sarrà-Escarré, MD, PhD, Victòria Clapés-Puig, MD, Jordi Trelis-Navarro, MD, Anna Sureda-Balarí, MD, PhD, Alberto Fernández De Sevilla-Ribosa, MD, PhD  Journal of Pain and Symptom Management  Volume 54, Issue 5, Pages 692-700 (November 2017) DOI: 10.1016/j.jpainsymman.2017.04.012 Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions

Fig. 1 Symptom frequency (%) at first visit at the integrative Multiple Myeloma Palliative outpatient clinic. N/V = nausea and vomiting. Journal of Pain and Symptom Management 2017 54, 692-700DOI: (10.1016/j.jpainsymman.2017.04.012) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions

Fig. 2 Changes in the median scores of the worst and average pain through the follow-up period (numbers outside the bars indicate outliers). Journal of Pain and Symptom Management 2017 54, 692-700DOI: (10.1016/j.jpainsymman.2017.04.012) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions

Fig. 3 Changes in the proportion of patients with moderate-to-severe (Numerical Visual Scale ≥5) worst and average pain over the course of the follow-up period. Journal of Pain and Symptom Management 2017 54, 692-700DOI: (10.1016/j.jpainsymman.2017.04.012) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions

Fig. 4 Changes in the median physical and emotional burden scores during the follow-up period (numbers outside the bars indicate outliers). Journal of Pain and Symptom Management 2017 54, 692-700DOI: (10.1016/j.jpainsymman.2017.04.012) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions